Tislelizumab as monotherapy or in sequential combination with lenvatinib for neoadjuvant treatment of resectable hepatocellular carcinoma: A prospective, phase II clinical study. NEO-ERA-01: A ...
Efficacy and safety of metronomic oral vinorelbine combined with PD-1 inhibitors as first-line therapy in advanced non-small-cell lung cancer in elderly patients. A phase II study of durvalumab, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results